Asha AI Pitch Deck Pdf For Investors | Virtual

Asha AI is a voice-enabled platform for remote patient care and clinical trials. It improves patient adherence, monitoring, and caregiver support through conversational AI and real-time insights, helping pharma run faster, compliant, and cost-effective virtual trials.

1. Empowering pharma to run virtual drug trials.
Finalist
Outstanding
Leadership Award
AgeTech Accelerator
Winner
Featured onFeatured onTIE50 Top
Companies
Presented atTRAILS FinalistLeadership
Summit

2. When my grandmother, Asha, was
diagnosed with cancer, we searched
for anything that could help increase
her chances of a positive outcome-
Only to realize that you can’t join
pharmaceutical trials virtually.
Asha AI Inc 2024
Asha AI Inc 2025 2

3. Asha AI Inc 2025
Meet Asha.
A conversational AI caregiver that
empowers pharma to run virtual
clinical trials.
3

4. Asha AI Inc 2025 4
Asha can intelligently converse with patients to answer
questions and get granular insights on health.
EDC/EHR
Devices + Services

5. $60.96B TAM
6.2% CAGR
Asha AI Inc 2025
Global Clinical Trials 2024
$12B SAM
Neurodegenerative
Accessibility
5.7% CAGR
$3.2B Mental Health
Sentiment Analysis
8% CAGR
Oncology
Care Management
5.5 CAGR
$8B
$3B
$15B
Focal Areas
Amount Spent on R&D Annually (USD)
Roche $13.5 B
Merck & Co $13.5 B
Pfizer $11.4 B
Janssen $11.6 B
Novartis $10 B
AstraZeneca $9.8 B
Bristol Myers Squibb $9.5 B
Eli Lilly $7.2 B
GSK $6.8 B
Sanofi $6.7 B
Capturing just 10% of trials sponsored by
the top 10 pharma companies at 10%
retail price of trial cost can result in a
revenue of $1B+
3
5

6. Data Cleaning Commercial Deployment
Integration and Compliance
RPM + Wearables
Raised $1.5B, IPO in 2018
11 acquisitions
Data Collection
AI Recruiting
$22M Raised
Asha AI Inc 2025
Asha addresses multiple pain points across the drug
lifecycle and is positioned to become the dominant
data collector in pharma.
D
r
u
g
D isco
v
e
r
y
D
a
t
a

C
o
l
l
e
c
t
i
o
n
D
a
t
a

C
l
e
a
n
i
n
g
C
o
m
m
e
r
c
i
a
l

D
e
p
l
o
y
m
e
n
t
Drug Discovery
AI Patient Education
AI Drug Discovery
Adverse Event Predictions
Automated Recruitment
Real-time Monitoring
Adverse Event Tracking
Risk Prediction
Patient Stratification
I
n
t
e
g
r
a
t
i
o
n

&
C
om plia
n
c
e
Wearables, caregivers
$3.38M Raised, Exited for
$24M
Trial RPM
$507M Raised,
$1.8B Premoney
Valuation
“80% of pharma said that they are planning to implement AI/ML”.
AI systems, deep
learning algos
$176M Raised
Series B raised in
Aug ’20 of $123M.
6

7. 01
02
03
04
Value Proposition
Technological Moat
Unique Value Proposition
Unfair Advantage
What Sets Us
Apart
Proactive, personalized
support, 24/7
Proprietary AI
Privacy-first architecture
Adaptive profiling
Future-proof security
Exclusive data
Top-tier partnerships
Asha AI Inc 2025 7

8. Billions in Unrealized Revenue
Get to market 30% faster.
Increased Compliance
Medication reminders
Patient education
Increased Likelihood of Clearance
Granular insights + 100+ biomarkers
Ease of Use, Automation,
Integration
Accessible + EDC to EHR Integration
Asha AI Inc 2025
“This is so exciting. I’ve been looking for something like
this for years!”
~ Head of Clinical Innovation
Global leader in cancer research
5X App Opens/Day!
Highest Engagement for any Health App
Conversational AI Health Platform
Patent Pending + PCT Patent Filed
8

9. $500M
per Customer
Asha AI Inc 2024Asha AI Inc 2024Asha AI Inc 2025
Sites/CRO
$200 ppm
Pharma
$1000 ppm
20302025
9
We have a revenue potential of $500M/yr+ for a single customer.
Our customers sell Asha for us, directly to other customers.
Targeting Phase I and renewing with each phase past commercial deployment
By Trial Pricing
Annual Subscription

10. Asha AI Inc 2025
10
2,000 Trials per Year
Trial 1 launch Q2/25
We’re launching our trial solution with the global leader in cancer research.
Supporting just 5% of their trials lands us over $500M in annual revenue.
Asha will plug directly into trials sponsored by
the top pharma companies in the world- Serving
as both a valuable customer and the top of
funnel to billions in revenue.
800 Trials per Year
Trial 1 launch Q2/25
Global Leader in
Cancer Research

11. Asha AI Inc 2024Asha AI Inc 2024Asha AI Inc 2025 11
Deploying Asha across just 20% of new Her2 patients is $120M in revenue.
50K new patients taking Her2 each year
$1K/pp/mo Retail Price
AZ is interested in deploying Asha with Her2
patients to detect coughing- preventing lung
disease and increasing positive outcomes.
Commercial Pipeline 2025

12. Rashmi Joshi
Chief Executive Officer
Serial entrepreneur with a track
record for spearheading venture-
backed businesses to fruitful
liquidity events with an average
100X return.
Dr. Yan Chow
Chief Medical Officer
Clinician turned healthcare
innovation expert and exited
founder of a $200M+ ARR
analytics startup. CINO @ Kaiser
Permanente & Amgen.
Our team of serial entrepreneurs, clinicians, technologists have
founded & exited healthcare & technology ventures valued at $2B+
Asha AI Inc 2025 12

13. National director
of innovation at
Blue Cross Blue
Shield
2 successful exits
Dr. Tony Quang
Clinical Relations
JD + MD, radiation
oncologist
Several medical
board of director
roles
Blake Ilstrup
General Counsel
Head of Orrick
PNW, Partner
GC to 10+
software & biotech
companies
Numerous
successful exits
Chris Taylor
Chief Financial Officer
Dave Gans
Chief Strategy Officer
National
authority on
medical ops
50+ patents and
publications
Asha AI Inc 2025
Anjali Joshi
Technologist
25+ years
experience
Data privacy
and
compliance
Chief Product Officer
13
Our founding team are comprised of industry experts.

14. Sean B.
House
Startup veteran
and CTO
Dr. Blaine
Warkentine
Clinician turned
Healthcare
Innovator
George
Gosieki
Healthcare IoT
expert
Dr. Haritha
Vankireddy
Geriatrician at Kaiser,
ex medical director of
Swedish Health
Dipankar
Ganguly
Expert in FDA
Regulated Point
of Care
Timothy
Marks
Multiple exits as
CTO & Founder,
including an IPO
John
Huffman
Founder/CTO of Philips
Healthcare Platform &
Tech Futurist
Anusha Halwai
Video Designer Product Manager
Gaurav Wagh
Backend Developer
Naveen Kumar
Fullstack Developer
Sanjeev Kumar
Marketing Manager
Sidak Kheterpal
Advisory Board
Supporting Team
Asha AI Inc 2025 14

15. Trial Acquisition $45,600/Trial
Patient Acquisition $45/Patient
B2B
$344,073
$ 687,718.40
$ 4,540,937.44
Year
Projected
Revenue
Trials
Served
Avg.
Participants/Trial
2025 $1.7M 28 300
2026 $8.0M 92 437
2027 $28.9M 192 753
2028 $59.8M 320 934
2031 $273M 792 1,720
We’ll achieve a top-line
of $273M by 2031.
Asha AI Inc 2025
CAC
CLTV
15

16. Asha AI Inc 2024
Join us in making life
saving clinical research
available to everyone.
Asha AI Inc 20 14
Email
[email protected]
Website
www.asha.healthcare
Book a call
https://calendly.com/rashmijoshi
Notable Investors: Bob Lee, CTO of Cash App, Dr. Sushil Beriwal, Global Leader in Oncology
Asha AI Inc 2025 Notable Investors: Bob Lee, CTO of Cash App, Dr. Sushil Beriwal, Global Leader in Oncology 16